Development and validation of a systematic UPLC–MS/MS method for simultaneous determination of three phenol impurities in ritonavir

A rationale for determining, testing, and controlling specific impurities in pharmaceuticals that possess potential for genotoxicity

Lutz Müller, Robert J. Mauthe, Christopher M. Riley et al. · Regulatory Toxicology and Pharmacology · 2006 · 461 citations

Pharmacy, Pharmaceutics, Toxicology +12

Advantages of application of UPLC in pharmaceutical analysis

Lucie Nováková, Ludmila Matysová, Petr Solich · Talanta · 2005 · 460 citations

Pharmacy, Pharmaceutical Analysis, Pharmaceutics +11

Use of ultra-performance liquid chromatography in pharmaceutical development

Stephen Wren, Pierre Tchelitcheff · Journal of Chromatography A · 2006 · 237 citations

Pharmacy, Pharmaceutical Analysis, Pharmaceutics +12

Sensitive and specific determination of eight antiretroviral agents in plasma by high-performance liquid chromatography–mass spectrometry

Katharina Rentsch · Journal of Chromatography B · 2003 · 72 citations

Pharmacy, Pharmaceutical Analysis, Pharmacology +14

Validation and application of a high-performance liquid chromatography–tandem mass spectrometric method for simultaneous quantification of lopinavir and ritonavir in human plasma using semi-automated 96-well liquid–liquid extraction

Perry G. Wang, Jack S. Wei, Grace Kim et al. · Journal of Chromatography A · 2006 · 62 citations

Pharmacy, Pharmacokinetics, Pharmacology +14